These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19727620)

  • 21. Computational analysis of ligand relationships within target families.
    Bajorath J
    Curr Opin Chem Biol; 2008 Jun; 12(3):352-8. PubMed ID: 18312862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational identification of proteins for selectivity assays.
    Yoon S; Smellie A; Hartsough D; Filikov A
    Proteins; 2005 May; 59(3):434-43. PubMed ID: 15770646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
    Sheinerman FB; Giraud E; Laoui A
    J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational tools for the analysis and visualization of multiple protein-ligand complexes.
    O'Brien SE; Brown DG; Mills JE; Phillips C; Morris G
    J Mol Graph Model; 2005 Dec; 24(3):186-94. PubMed ID: 16169759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network and pathway analysis of compound-protein interactions.
    Brennan RJ; Nikolskya T; Bureeva S
    Methods Mol Biol; 2009; 575():225-47. PubMed ID: 19727618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.
    Brannetti B; Via A; Cestra G; Cesareni G; Helmer-Citterich M
    J Mol Biol; 2000 Apr; 298(2):313-28. PubMed ID: 10764600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge-based design of target-focused libraries using protein-ligand interaction constraints.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2006 Jan; 49(2):490-500. PubMed ID: 16420036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicted role for the archease protein family based on structural and sequence analysis of TM1083 and MTH1598, two proteins structurally characterized through structural genomics efforts.
    Canaves JM
    Proteins; 2004 Jul; 56(1):19-27. PubMed ID: 15162483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based development of target-specific compound libraries.
    Orry AJ; Abagyan RA; Cavasotto CN
    Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A chemical genetic method for generating bivalent inhibitors of protein kinases.
    Hill ZB; Perera BG; Maly DJ
    J Am Chem Soc; 2009 May; 131(19):6686-8. PubMed ID: 19391594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of c-Met kinase domain complexes: a new specific catalytic site receptor model for defining binding modes of ATP-competitive ligands.
    Asses Y; Leroux V; Tairi-Kellou S; Dono R; Maina F; Maigret B
    Chem Biol Drug Des; 2009 Dec; 74(6):560-70. PubMed ID: 19909299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of a three-dimensional multitarget activity landscape.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2012 Nov; 52(11):2876-83. PubMed ID: 23113585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical potential-based amino acid similarity matrices for aligning distantly related protein sequences.
    Tan YH; Huang H; Kihara D
    Proteins; 2006 Aug; 64(3):587-600. PubMed ID: 16799934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery.
    Tintori C; Corradi V; Magnani M; Manetti F; Botta M
    J Chem Inf Model; 2008 Nov; 48(11):2166-79. PubMed ID: 18942779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural genomics-impact on biomedicine and drug discovery.
    Weigelt J
    Exp Cell Res; 2010 May; 316(8):1332-8. PubMed ID: 20211166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting polypharmacology by binding site similarity: from kinases to the protein universe.
    Milletti F; Vulpetti A
    J Chem Inf Model; 2010 Aug; 50(8):1418-31. PubMed ID: 20666497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.